By Hugo Francisco de Souza Emerging research suggests reversible RNA editing mechanisms may influence heart disease biology while opening new avenues for biomarkers and next-generation cardiovascular ...

Scientists in the laboratory of Rendong Yang, Ph.D., associate professor of Urology, have developed a new large language model that can interpret transcriptomic data in cancer cell lines more ...

According to Precedence Research, the global RNA analysis market size is expected to be worth USD 23.39 billion by 2035, increasing from USD 10.21 billion in 2026, with a strong CAGR of 9.65% from ...

A 45-nucleotide strand of RNA can now synthesize both its mirror-image complement and a copy of itself, bringing scientists closer than ever to demonstrating how life could have emerged from chemistry ...

Lilac Biosciences, a biotechnology company spun out of the Giuliani RNA Center at Brown University, developing quantitative RNA-based analytical tools, announced a research collaboration with Soin ...

Diabetic foot ulcers are slow-healing and increase the risk of infections and amputation. Researchers at Karolinska ...

Researchers are embarking on the RNA equivalent of the Human Genome Project, including sequencing all the chemical ...

AMES, Iowa -- When Walter Moss first began studying RNA structures, it was a somewhat obscure realm of basic science. A handful of RNA-based drug treatments had been approved for specific diseases, ...

QIMR Berghofer scientists have discovered a cancer-fighting RNA molecule that could hold the key to a new way of treating the ...

The research explores how CRISPR can be used to edit RNA. A team at Montana State University published research that shows how RNA, the close chemical cousin to DNA, can be edited using CRISPRs. The ...

WEST LAFAYETTE, Ind. — Ribonucleic acid, commonly known as RNA, is involved in many biological functions, and some, including gene silencing, are utilitized to cure diseases. RNA has recently gained ...

The Mass General Brigham Gene and Cell Therapy Institute (GCTI) today announced it has launched the RNA Therapeutics Core, a first-of-its-kind, state-of-the-art facility and resource to advance the ...